SCHEMBL29919361

SCHEMBL29919361

CCOC(OCC)c1cc2ccc(CN)cc2n1C

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ CSNK2A1 P68400 4/20 0.31
▸ ASIC3 Q9UHC3 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23482077 1.00 CSNK2A1 (0.31) CSNK2A1ASIC3
Ammonia Solution, Strong SCHEMBL28878686 0.79 MAPT (0.38) —
SCHEMBL29965268 0.76 BRPF1 (0.39) —
SCHEMBL23458895 0.76 BRPF1 (0.39) —
SCHEMBL23458917 0.67 GAA (0.37) CSNK2A1
SCHEMBL29919173 0.67 GAA (0.37) CSNK2A1
SCHEMBL111470 0.63 CYP2A6 (0.49) ASIC3
SCHEMBL9320188 0.63 BRPF1 (0.62) —
SCHEMBL904805 0.62 MPO (0.49) CSNK2A1
SCHEMBL29585470 0.62 MPO (0.49) CSNK2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4069694-A1 POLYHETEROCYCLIC COMPOUNDS AS METTL3 INHIBITORS Storm Therapeutics Ltd (GB) 2022-10-12 — — EP disclosed
CN-115151540-A Polyheterocyclic compounds as METTL3 inhibitors 风暴治疗有限公司 2022-10-04 — — CN disclosed
Send feedback